Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.5724
-0.0676
(-10.56%)
At close: April 7 at 4:00:02 PM EDT
0.5699
-0.00
(-0.44%)
After hours: April 7 at 7:31:38 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | 0.08 | -0.08 | -0.06 | -0.26 |
| Low Estimate | -0.12 | -0.14 | -0.57 | -0.63 |
| High Estimate | 0.28 | -0.01 | 0.44 | -0.03 |
| Year Ago EPS | -0.27 | -0.22 | -0.81 | -0.06 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 6 |
| Avg. Estimate | 16.67M | 4.17M | 29.86M | 24.84M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 50M | 25M | 125M | 75M |
| Year Ago Sales | -- | -- | -- | 29.86M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -16.81% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.36 | -0.3 | -0 | -0.2 |
| EPS Actual | -0.27 | -0.22 | -0.33 | -0.11 |
| Difference | 0.09 | 0.08 | -0.33 | 0.09 |
| Surprise % | 25.52% | 25.52% | -16,651.27% | 44.80% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.08 | -0.08 | -0.06 | -0.26 |
| 7 Days Ago | -0.19 | -0.17 | -0.41 | -0.41 |
| 30 Days Ago | -0.19 | -0.17 | -0.41 | -0.41 |
| 60 Days Ago | -0.19 | -0.17 | -0.41 | -0.41 |
| 90 Days Ago | -0.19 | -0.17 | -0.41 | -0.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 2 |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MCRB | 129.63% | 65.91% | 92.27% | -313.89% |
| S&P 500 | 6.56% | 6.52% | 9.72% | 14.29% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 3/20/2025 |
| Maintains | Goldman Sachs: Sell to Sell | 3/14/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/14/2024 |
| Maintains | Chardan Capital: Buy to Buy | 11/13/2024 |
| Downgrade | JP Morgan: Neutral to Underweight | 10/24/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 9/13/2024 |
Related Tickers
SCPH scPharmaceuticals Inc.
2.3300
+0.43%
ARDX Ardelyx, Inc.
4.4500
-2.20%
MRSN Mersana Therapeutics, Inc.
0.3053
+0.79%
XFOR X4 Pharmaceuticals, Inc.
0.2121
-1.16%
PDSB PDS Biotechnology Corporation
0.9632
+1.38%
SYRS Syros Pharmaceuticals, Inc.
0.0241
+33.89%
ATYR aTyr Pharma, Inc.
2.8500
+8.78%
CHRS Coherus BioSciences, Inc.
0.8215
+5.08%
PHAT Phathom Pharmaceuticals, Inc.
4.8700
-0.20%
YMAB Y-mAbs Therapeutics, Inc.
4.2800
-5.73%